JCR Pharmaceuticals (JCRRF) Short Interest Ratio & Short Volume

$4.70

0.00 (0.00%)

(As of 09/6/2024 ET)

Stock Analysis Chart Headlines Short Interest

JCR Pharmaceuticals Short Interest Data

JCR Pharmaceuticals (JCRRF) has a short interest of 352,400 shares. This marks a -7.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 267 shares to cover all short positions.

Current Short Interest: 352,400 shares
Previous Short Interest: 380,200 shares
Change Vs. Previous Month: -7.31%
Dollar Volume Sold Short: $1.52 million
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: August 15, 2024

Today's Trading Volume: 0 shares
Average Trading Volume: 267 shares
Today's Volume Vs. Average: 0%

Short Selling JCR Pharmaceuticals?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for JCR Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

JCRRF Short Interest Over Time

JCRRF Days to Cover Over Time

JCRRF Percentage of Float Shorted Over Time

Ad Deal Maker

The solution to fast food’s wage hike crisis

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.

JCR Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	352,400 shares	$1.52 million	-7.3%	N/A	0	$4.30
7/31/2024	380,200 shares	$1.64 million	-6.1%	N/A	3802	$4.30
7/15/2024	405,000 shares	$2.11 million	-21.8%	N/A	0	$5.22
6/30/2024	517,600 shares	$2.70 million	+15.8%	N/A	0	$5.22
6/15/2024	447,000 shares	$2.33 million	-17.8%	N/A	0	$5.22
5/31/2024	544,000 shares	$2.84 million	+0.8%	N/A	0	$5.22
Get the Latest News and Ratings for JCRRF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for JCR Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/15/2024	539,500 shares	$2.82 million	+5.3%	N/A	0	$5.22
4/30/2024	512,400 shares	$2.67 million	-7.0%	N/A	0	$5.22
4/15/2024	551,200 shares	$2.88 million	-6.7%	N/A	5512	$5.22
3/31/2024	590,800 shares	$3.66 million	-6.0%	N/A	0	$6.20
3/15/2024	628,800 shares	$3.90 million	-20.6%	N/A	0	$6.20
2/29/2024	791,700 shares	$4.91 million	-2.7%	N/A	0	$6.20
2/15/2024	813,800 shares	$5.05 million	+5.5%	N/A	8138	$6.20
1/15/2024	726,700 shares	$6.57 million	-3.3%	N/A	0	$9.04
12/31/2023	751,100 shares	$6.79 million	-0.1%	N/A	0	$9.04
12/15/2023	752,000 shares	$6.80 million	-3.2%	N/A	0	$9.04
11/30/2023	776,700 shares	$7.02 million	-5.1%	N/A	0	$9.04
11/15/2023	818,200 shares	$7.40 million	+0.2%	N/A	0	$9.04
10/31/2023	816,300 shares	$7.38 million	+0.6%	N/A	0	$9.04
10/15/2023	811,100 shares	$7.33 million	-1.1%	N/A	8111	$9.04
9/30/2023	820,000 shares	$8.29 million	-5.8%	N/A	8200	$10.11
9/15/2023	870,600 shares	$8.24 million	+3.7%	N/A	0	$9.47
8/31/2023	839,900 shares	$7.95 million	-1.6%	N/A	0	$9.47
8/15/2023	853,300 shares	$8.08 million	-4.8%	N/A	0	$9.47
7/31/2023	896,300 shares	$8.49 million	+20.9%	N/A	8963	$9.47
7/15/2023	741,600 shares	$7.04 million	+13.4%	N/A	0	$9.49
6/30/2023	654,100 shares	$6.21 million	-2.9%	N/A	6541	$9.49
6/15/2023	673,300 shares	$7.24 million	+9.4%	N/A	0	$10.76
5/31/2023	615,400 shares	$6.62 million	+53.9%	N/A	0	$10.76
5/15/2023	400,000 shares	$4.30 million	+11.6%	N/A	0	$10.76
4/30/2023	358,500 shares	$3.86 million	+17.5%	N/A	0	$10.76
4/15/2023	305,000 shares	$3.28 million	+8.2%	N/A	3050	$10.76
3/31/2023	281,800 shares	$2.93 million	+4.3%	N/A	2818	$10.40
3/15/2023	270,200 shares	$2.81 million	-5.4%	N/A	2702	$10.40
2/28/2023	285,700 shares	$3.54 million	-0.2%	N/A	0	$12.38
2/15/2023	286,300 shares	$3.54 million	-10.5%	N/A	1431.5	$12.38
1/31/2023	319,700 shares	$6.15 million	+11.4%	N/A	0	$19.24
1/15/2023	287,100 shares	$5.52 million	-13.1%	N/A	0	$19.24
12/30/2022	330,400 shares	$6.36 million	-5.9%	N/A	3304	$19.24
12/15/2022	351,100 shares	$6.76 million	-65.0%	N/A	1.1	$19.24
Say Goodbye to the US Dollar (Ad) The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... [RUSH MY FREE GUIDE]
11/30/2022	1,004,100 shares	$19.32 million	+120.8%	N/A	0	$19.24
11/15/2022	454,800 shares	$8.75 million	+14.6%	N/A	0	$19.24
10/31/2022	397,000 shares	$7.64 million	+3.9%	N/A	0	$19.24
10/15/2022	382,200 shares	$7.35 million	+1.0%	N/A	3822	$19.24
9/30/2022	378,300 shares	$7.28 million	+0.3%	N/A	3783	$19.24
9/15/2022	377,200 shares	$7.26 million	-63.3%	N/A	1.3	$19.24
8/31/2022	1,027,200 shares	$19.76 million	+22.5%	N/A	0	$19.24
8/15/2022	838,500 shares	$16.13 million	+39.5%	N/A	8385	$19.24
7/31/2022	601,000 shares	$11.56 million	-34.2%	N/A	751.3	$19.24
7/15/2022	912,800 shares	$16.38 million	+91.5%	N/A	0	$17.95
6/30/2022	476,600 shares	$8.55 million	+2.1%	N/A	0	$17.95
6/15/2022	466,800 shares	$8.38 million	+0.5%	N/A	0	$17.95
5/31/2022	464,400 shares	$8.34 million	-8.5%	N/A	0	$17.95
5/15/2022	507,600 shares	$9.11 million	-1.8%	N/A	0	$17.95
4/30/2022	517,100 shares	$9.28 million	+3.8%	N/A	0	$17.95
4/15/2022	498,400 shares	$8.95 million	+3.4%	N/A	0	$17.95
3/31/2022	482,000 shares	$8.65 million	-14.4%	N/A	0	$17.95
3/15/2022	563,300 shares	$10.11 million	-26.9%	N/A	0	$17.95
2/28/2022	771,000 shares	$13.84 million	+3.4%	N/A	0	$17.95
2/15/2022	745,500 shares	$13.38 million	+1.0%	N/A	0	$17.95
1/31/2022	738,500 shares	$13.26 million	-23.6%	N/A	2461.7	$17.95
1/15/2022	967,100 shares	$26.98 million	+43.5%	N/A	0	$27.90
12/31/2021	674,100 shares	$18.81 million	+25.1%	N/A	0	$27.90
12/15/2021	538,700 shares	$15.03 million	+16.6%	N/A	0	$27.90
11/30/2021	462,000 shares	$12.89 million	-1.6%	N/A	0	$27.90
11/15/2021	469,400 shares	$13.10 million	+11.4%	N/A	0	$27.90
10/29/2021	421,500 shares	$11.76 million	-4.8%	N/A	0	$27.90
10/15/2021	442,800 shares	$12.35 million	-1.3%	N/A	0	$27.90
9/30/2021	448,400 shares	$12.51 million	-18.4%	N/A	0	$27.90
9/15/2021	549,600 shares	$15.33 million	-36.9%	N/A	5496	$27.90
8/31/2021	871,500 shares	$24.31 million	+22.7%	N/A	0	$27.90
8/13/2021	710,100 shares	$19.81 million	+57.9%	N/A	0	$27.90
7/30/2021	449,800 shares	$12.55 million	-7.2%	N/A	0	$27.90
7/15/2021	484,600 shares	$13.52 million	-1.8%	N/A	0	$27.90
6/30/2021	493,300 shares	$13.76 million	+0.7%	N/A	0	$27.90
6/15/2021	490,100 shares	$13.67 million	+1.9%	N/A	0	$27.90
5/28/2021	481,000 shares	$13.42 million	+16.6%	N/A	0	$27.90
5/14/2021	412,700 shares	$11.51 million	-7.2%	N/A	0	$27.90
4/30/2021	444,500 shares	$12.40 million	-22.4%	N/A	4445	$27.90
4/15/2021	573,100 shares	$19.40 million	+51.4%	N/A	0	$33.85
3/31/2021	378,500 shares	$12.81 million	+42.0%	N/A	0	$33.85
3/15/2021	266,500 shares	$9.02 million	+27.6%	N/A	0	$33.85
2/26/2021	208,900 shares	$7.07 million	+25.4%	N/A	2089	$33.85
2/12/2021	166,600 shares	$0.00	-33.6%	N/A	0	$0.00
1/29/2021	251,000 shares	$0.00	+48.9%	N/A	0	$0.00
1/15/2021	196,800 shares	$0.00	+37.4%	N/A	0	$0.00
12/31/2020	125,700 shares	$0.00	-36.1%	N/A	0	$0.00

JCRRF Short Interest - Frequently Asked Questions

What is JCR Pharmaceuticals' current short interest?: Short interest is the volume of JCR Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 352,400 shares of JCRRF short. Learn More on JCR Pharmaceuticals' current short interest.
Is JCR Pharmaceuticals' short interest increasing or decreasing?: JCR Pharmaceuticals saw a decline in short interest in August. As of August 15th, there was short interest totaling 352,400 shares, a decline of 7.3% from the previous total of 380,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does JCR Pharmaceuticals' short interest compare to its competitors?: Here is how the short interest of companies in the sector of "medical" compare to JCR Pharmaceuticals: Eli Lilly and Company (0.74%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short JCR Pharmaceuticals stock?: Short selling JCRRF is an investing strategy that aims to generate trading profit from JCR Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against JCR Pharmaceuticals?: A short squeeze for JCR Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of JCRRF, which in turn drives the price of the stock up even further.
How often is JCR Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JCRRF, twice per month. The most recent reporting period available is August, 15 2024.